Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

13,352 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. (2005, methodology): “We excluded depression and dementia to focus on patients who would be most likely to adhere to recommendations and understand health information.12,13 Among the 5% sample in 2001, half of the beneficiaries had at least 2 of these 9 chronic diseases and 80% had at least 1 other condition.1 We identif”
Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function (2016, neutral): “(%) 1/196 (1) 3/421 (1) 8/423 (2) 4/335 (1) 25/622 (4)”
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019 (2019, background): “Individualization of COPD pharmacological treatment has progressed significantly since the days of FEV1 guided pharmacological management(47).”
Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease (2012, background): “PR has been shown to be the most effective non-pharmacological intervention for improving health status in COPD patients and has become a standard of care for these patients [2].”
STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. (2008, background): “Regular inhaled 2-agonist or anticholinergic agent for mild-to-moderate asthma or COPD [Buist et al. 2006].”